Literature DB >> 11535991

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.

S Morecki1, Y Gelfand, A Nagler, R Or, E Naparstek, G Varadi, D Engelhard, A Akerstein, S Slavin.   

Abstract

We have investigated the immune status of patients with hematologic malignancies treated with a low intensity conditioning in preparation for allogeneic stem cell transplantation. Conditioning consisted of fludarabine, anti-T lymphocyte globulin and low-dose busulfan, followed by infusion of allogeneic blood stem cells. This protocol resulted in rapid engraftment and complete replacement of host with donor hematopoietic cells. Immunological parameters of these patients were compared to those patients who were conditioned by an aggressive myeloablative regimen. Distribution of cell surface markers of lymphocyte subsets from both groups of patients was similar, but different from that of normal control cells. Reduced intensity or non-myeloablative conditioning prior to allogeneic stem cell transplantation (NST), hardly lowered the normal T cell-dependent mitogenic response even during the early period following transplant, while the myeloablative treatments resulted in a suppressed mitogenic reaction and in slow immune recovery. Reactivity of non-MHC restricted cytotoxic T cells was also at a normal level in patients who were treated with NST. We conclude that stem cell engraftment following reduced conditioning may result in early reconstitution of immune responses assessed in vitro. We hypothesize that clinical application of NST may lead to faster development of effective immune responses against residual host-type malignant and abnormal non-malignant hematopoietic cells, although the role of fludarabine on post-transplant infections remains to be investigated in a larger cohort of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535991     DOI: 10.1038/sj.bmt.1703118

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  15 in total

Review 1.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

Review 3.  Umbilical cord blood graft engineering: challenges and opportunities.

Authors:  P A Thompson; K Rezvani; C M Hosing; B Oran; A L Olson; U R Popat; A M Alousi; N D Shah; S Parmar; C Bollard; P Hanley; P Kebriaei; L Cooper; J Kellner; I K McNiece; E J Shpall
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Adaptive NK cell reconstitution is associated with better clinical outcomes.

Authors:  Frank Cichocki; Emily Taras; Flavia Chiuppesi; John E Wagner; Bruce R Blazar; Claudio Brunstein; Xianghua Luo; Don J Diamond; Sarah Cooley; Daniel J Weisdorf; Jeffrey S Miller
Journal:  JCI Insight       Date:  2019-01-24

5.  JC polyomavirus reactivation is common following allogeneic stem cell transplantation and its preemptive detection may prevent lethal complications.

Authors:  T Wittmann; N Horowitz; N Benyamini; I Henig; T Zuckerman; J M Rowe; Z Kra-Oz; M Szwarcwort Cohen; I Oren; I Avivi
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

6.  The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation.

Authors:  Roberta Fedele; Massimo Martino; Cristina Garreffa; Giuseppe Messina; Giuseppe Console; Domenica Princi; Antonella Dattola; Tiziana Moscato; Elisabetta Massara; Elisa Spiniello; Giuseppe Irrera; Pasquale Iacopino
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

Review 7.  The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases.

Authors:  Michael Maris; Rainer Storb
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 8.  Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  George E Georges; Rainer Storb
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

Review 9.  T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome.

Authors:  Ahmed Gaballa; Mikael Sundin; Arwen Stikvoort; Muhamed Abumaree; Mehmet Uzunel; Darius Sairafi; Michael Uhlin
Journal:  Int J Mol Sci       Date:  2016-10-11       Impact factor: 5.923

10.  Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients.

Authors:  Shalaka S Hampras; Frederick L Locke; Julio C Chavez; Nishit S Patel; Anna R Giuliano; Kyle Miller; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  Leuk Lymphoma       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.